1. Main purpose of participant’s research work:
Options: clinical research, routine diagnostics, diagnostics research, clinical trials, patient treatment, disease research, drug research or other.
2. Top three (associated) therapeutic areas:
relating to participants work with antibiotics or antibiotic resistance (e.g. general bacterial infections, infections associated with autoimmune disease etc). Options: arthritis, autoimmune diseases, general bacterial infections, bone metabolism, cancer, cardiovascular, central nervous system, dermatology, endocrine, gastrointestinal, genitourinary system, haematology, inflammation, metabolic disorders, musculoskeletal disorders, nutrition, obstetrics and gynaecology, ophthalmology, pain, respiratory, viral infections or other.
3. Main activity:
Participants disclosures relating to antibiotics and/or antibiotic resistance. Options: research to identify naturally occurring antibiotics; research to identify semisynthetic, antibiotics, research to identify synthetic antibiotics, new mechanistic strategies to combat antibiotic resistance, new bacterial drug targets
new diagnostics for identifying bacterial types, genetic studies of resistance genes, or the resistome, other.
4. Antibiotic source:
Participants disclosures on the main source of the antibiotics on which they are working. Options: natural, semisynthetic, synthetic, other
5. Gram negative bacteria:
Participants’ disclosures on the top three gram negative bacteria, with which they are working. Options: Acinetobacter species, Actinobacillus species, Bacteroides fragilis, Bacteroides sp., Bordetella pertussis, Borrelia burgdorferi, Brucella abortus, Brucella canis, Brucella melitensis, Brucella suis, Campylobacter jejuni, Chlamydia pneumoniae, Chlamydia trachomatis, Chlamydophila pneumoniae, Chlamydophila psittaci, Chlymidia peumoniae, Cyanobacteria, Enterobacter, Erwinia s
Copyright©2012 Vocus, Inc.
All rights reserved